Toxic epidermal necrolysis (TEN) is a rare skin condition, most often drug-induced, known for its skin detachment and high mortality. In general, acute TEN is considered a T-cell mediated, type IV hypersensitivity disorder. It mostly results from a cumulative effect of risks from the drug structure, drug metabolism, HLA alleles and T cell clonotypes. However, the precise mechanism of TEN is still unknown.
Introduction
Toxic epidermal necrolysis (TEN) is a rare skin condition, most often drug-induced, known for its skin detachment and high mortality (Fig. 1) . The incidence rate is nearly 1 per million per year and the average mortality rate is as high as 25 50%. Following a flu-like prodrome, erythematous or purpuric macules appear on the skin. These macules coalesce to become flaccid blisters that slough off as areas of necrotic epidermis. Drugs are the most common cause, with allopurinol, sulfonamides, and carbamazepine especially noted 1 . In general, acute TEN is considered a T-cell mediated, type IV hypersensitivity disorder 2 . It mostly results from a cumulative effect of risks from the drug structure, drug metabolism, HLA alleles and T cell clonotypes 3 . However, the precise mechanism of TEN is still unknown. Apoptosis or necroptosis causes keratinocytes to lose their shape and adhesion, and necrosis predominates within a few days. Total epidermal necrosis separates the epidermis from the dermis 4, 5 . TEN is regarded as an immune reaction with predominantly CD8+ T lymphocytes, monocytes/macrophages, and natural killer (NK) cells. Impaired regulatory
T-cells (T-reg cells), T helper 17 (Th17) cells, cytotoxic
granules such as perforin-granzyme and granulysin, tumor necrosis factor α (TNFα) 6 , annexin, microRNA (miR)-18a-5p, and drug metabolites are all thought to be involved. The proposed mechanisms of apoptosis can be divided into 2 groups: the extrinsic and intrinsic pathways. The intrinsic pathway involves electrophilic toxic drug metabolites produced by keratinocytes 5 7 . Drug metabolites damage the mitochondria and produce reactive oxygen species, leading to production of TNFα, which damages the cell further 8 
. The extrinsic pathway includes
Fas-Fas ligand (FasL) interactions, soluble FasL (sFasL), perforin-granzyme, granulysin, TNFα, and miR-18a-5p, with cytotoxic lymphocyte and monocyte/macrophage involvement. Annexin induces cell death through necroptosis, and this can be considered an extrinsic pathway 5 7,9,10 . The CD137L-CD137 system of monocytes augments damaging effects of CD8+ T cells, and CD94/ NKG2C+ cytotoxic T cells binding to keratinocytes expressing HLA-E induce cell death ( Table 1) 6, 11 .
Drug Antigen Presentation
An allergic immune response in which an antigenic drug-host tissue complex is made is thought to start the formed by binding to carrier proteins recognized by T cells. These are presented to T cells through antigenpresenting cells (APCs). This is because common skin reaction-inducing drugs tend to be small molecules. Drug hypersensitivity to a hapten-peptide complex is less likely to be HLA-restricted because the protein has multiple binding sites. A variety of drug-bound peptides is available for loading onto different types of HLA alleles.
In the p-i theory, drugs bind to T cell receptors and/or major histocompatibility complex molecules to trigger specific T cells. The drug does not bind to proteins as in the hapten/pro-hapten theory. A hapten is not made and not involved. This theory was proposed when it was found that even fixed APCs were able to activate specific T cell clones although they cannot process antigens. In the altered peptide model, the drug binds directly to the pocket of a specific HLA but does not bind to a closely related HLA molecule. HLA and the drug form a complex before the HLA molecules are loaded with peptides inside the cell. As a result, self peptides that bind to the HLA-drug complex for display to TCR are altered from the self-peptides that bind to the original HLA. Thus different T cell are triggered 3, 5, 7, 10 . In the altered TCR repertoire, the same thing happens as in the altered peptide repertoire, but this time the drug binds to a specific TCR, and changes the structure of the TCR. The HLA-drug-TCR may activate the immune reaction leading to TEN 7 .
It can be thought that the p-i and altered peptide repertoire theories favor specific HLA phenotypes. Also in the TCR repertoire theory, the favoring of specific HLA phenotypes is likely. A drug serving as an allergen binds directly to specific HLA molecules and/or TCRs without prior processing by antigen-presenting cells. In the p-i theory, the interactions of certain drugs with immune receptors cause a drug hypersensitivity reaction 12 15 . Abacavir and carbamazepine are thought to cause TEN through the altered peptide model 15, 16 . A direct interaction between carbamazepine and HLA-B* 1502 may induce TEN 17, 18 . Genetic susceptibility may be explained by the possibility that specific drug-related HLA alleles increases the likelihood of TEN happening 19 21 . 23 . In maculopapular rashes, it has been reported that CD4+ T lymphocytes are the most common and drug-specific T cells 24 .
CD8+ T Lymphocytes

T-reg Cells
It has been proposed that an enhancement of T-cell ac- T-reg cells collected from the peripheral blood of TEN patients do not inhibit T-cells. The number of T-reg cells in TEN patients does not appear to differ from that of normal patients, but their function is impaired in the acute phase of TEN 25 .
Th17 Cells
Th17 cells are a subset of CD4+ T cells found to be in a high percentage of SJS/TEN patients compared to normal patients and those with maculopapular rash from 2 6 days after onset 26 . Th17 cells produce IL-17 and IL-22 27 .
There are more IL-17-producing CD4+ T cells in SJS/ 
Fas-FasL Interaction and Perforin-Granzyme
Cytotoxic is responsible for triggering apoptosis through interaction with membrane-bound Fas in keratinocytes, inducing the same reactions as the Fas-FasL interaction 6 . This has been identified in vitro, with TEN patient serum inducing apoptosis in cultured keratinocytes 34 . An increase in serum sFasL has been observed in the early stages of TEN, with the levels of sFasL being highest before the appearance of mucocutaneous lesions, and decreasing approximately 5 days after the appearance of the lesions, suggesting a role in the pathogenesis of TEN 35 . However, the degree of involvement of sFasL is unknown as it is not specific to TEN and is observed in other drug reactions.
Furthermore, the cytotoxicity of sFasL is 1,000 times less than that of membrane-bound FasL 6, 31 . Granulysin is a 9-kD cationic protein that binds to the cell surface based on charge interactions without a specific receptor. The precursor is a 15-kD granulysin protein. Both proteins are cytotoxic, but the 9-kD protein is secreted by cytotoxic cells in a granule, whereas the 15-kD protein is secreted by exocytosis. Granulysin is secreted by CD8+ T-cells,
NK, and NKT cells. NKT cells are T-cells with properties
of both CD8+ T-cells and NK cells. Granulysin is involved in apoptosis, but also has antitumor, antimicrobial, chemotactic, and proinflammatory properties 4 . The negative charge on the molecule disrupts the positively charged cell membrane when binding, and this charge relationship damages the mitochondria, resulting in cell death 6 . High serum levels of granulysin have been detected 2 4 days before TEN 36 . In addition, granulysin levels are higher than perforin, granzyme, or sFasL levels in the blister fluid from TEN patients. Injecting granulysin into mouse skin results in induction of skin lesions similar to those in TEN, whereas depletion of granulysin mitigates cytotoxic effects. Serum granulysin levels directly relate to skin lesion severity, unlike FasL 37 . However, as noted with FasL, granulysin is not specific to TEN, and is also observed in other drug reactions 6 .
Annexin A1 and Formyl Peptide Receptor 1 (FPR1)
Annexin A1 binding to FPR1 can trigger keratinocyte death, suggesting it may be involved in the pathogenesis of SJS/TEN. It is a direct mechanism with cell contact 38 .
Annexin is an immune regulatory protein secreted from immune cells, including monocytes, and has many functions, including membrane aggregation, inflammation, phagocytosis and proliferation 39 . FPR1 is a type of G protein-coupled receptor involved in tissue damage 40 
CD137L-CD137
Monocytes infiltrating lesions express costimulatory factors such as CD80/86 and CD137L. These activate Tcells through their receptors CD28 and CD137, along with binding of TCR and the cognate peptide major histocompatibility complex. Specifically, the CD137L-CD137 system augments the damaging effect of CD8+ T-cells by facilitating avoidance of cell death and, subsequently, continuous proliferation. Additionally, this system signals to dendritic cells via reverse signal transduction, which results in increased potency of T-cell responses with production of IL-12, increased IFNγ, and decreased IL-10 6 .
CD94/NKG2C+
In SJS/TEN patients, CD94/NKG2C+ peripheral blood T and NK cells are increased during the acute phase of SJS/TEN. HLA-E-specific activating receptor CD94/ NKG2C+ can trigger TCR-independent cytotoxicity in cytotoxic T lymphocytes. The keratinocytes from affected skin of SJS/TEN patients express HLA-E, and the binding of those CD94/NKG2C+ cytotoxic lymphocytes may cause their death 11 .
Conclusion
The pathogenesis of TEN has not been established, and there are several proposed mechanisms. The mechanism is complex, and there is still much to be investigated.
New findings will contribute to the identification of effective active methods of intervention.
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